SCHEMBL23625815

SCHEMBL23625815

Clc1cc(-n2c3ccccc3c3cc(-c4ccccc4)ccc32)cc2c1sc1ccc3oc4ccccc4c3c12

nearest known ligand 0.33

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 2/20 0.33
▸ PLA2G4A P47712 2/20 0.33
▸ LIMK1 P53667 1/20 0.32
▸ PLA2G10 O15496 1/20 0.30
▸ DNM1 Q05193 1/20 0.30
▸ TSPO P30536 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26534982 0.91 KDM4E (0.35) —
SCHEMBL26534918 0.91 AHR (0.35) —
SCHEMBL25741471 0.89 DNM1 (0.31) PLA2G2APLA2G4ADNM1
SCHEMBL23625901 0.88 KDM4E (0.32) —
SCHEMBL23625816 0.85 LPL (0.32) PLA2G2APLA2G4A
SCHEMBL21615972 0.84 LIMK1 (0.31) PLA2G2APLA2G4ALIMK1
SCHEMBL23625905 0.83 AHR (0.32) —
SCHEMBL23058228 0.82 PLA2G2A (0.38) PLA2G2APLA2G4APLA2G10DNM1TSPO
SCHEMBL23634596 0.81 KDM4E (0.35) —
SCHEMBL21615975 0.80 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11787818-B2 Compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2023-10-17 — — US disclosed
US-11787818-B2 Compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2023-10-17 — — US disclosed
US-20210206778-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2021-07-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11787818-B2 Compound and organic light emitting device comprising the same NCOA4, RCOR1, NR2E3 PLA2G2A 4006/4885PLA2G4A 3752/4885LIMK1 1400/4885
US-20210206778-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME NCOA4, NR2E3, NR4A1 PLA2G2A 3670/4885PLA2G4A 3410/4885LIMK1 1399/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback